SCHEMBL30033533

SCHEMBL30033533

O=c1[nH]c2cc(Cl)ccc2c(=O)n1-c1cncc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.57
▸ HTT P42858 1/20 0.57
▸ GAA P10253 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ CA12 O43570 1/20 0.48
▸ KMT2A Q03164 2/20 0.46
▸ NPEPPS P55786 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ TP53 P04637 1/20 0.43
▸ CMA1 P23946 1/20 0.43
▸ HAVCR2 Q8TDQ0 1/20 0.42
▸ PKM P14618 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ AURKA O14965 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30033042 0.91 KDM4E (0.57) KDM4EHTTGAAALDH1A1CA9
SCHEMBL27377871 0.89 KDM4E (0.50) KDM4EHTTGAAALDH1A1CA9
SCHEMBL27377885 0.89 KDM4E (0.51) KDM4EHTTGAAALDH1A1CA9
SCHEMBL27377863 0.88 KDM4E (0.46) KDM4EHTTGAAALDH1A1CA9
SCHEMBL27192169 0.87 NPEPPS (0.47) KDM4EHTTGAAALDH1A1CA9
SCHEMBL31509793 0.86 NPEPPS (0.57) KDM4EHTTGAAALDH1A1CA9
SCHEMBL27191850 0.85 KDM4E (0.44) KDM4EHTTGAANPEPPSTP53
SCHEMBL29328549 0.85 FEN1 (0.53) KDM4EHTTGAAALDH1A1KMT2A
SCHEMBL27192346 0.85 KDM4E (0.46) KDM4EHTTGAANPEPPSTP53
SCHEMBL27191731 0.85 TNKS2 (0.46) KDM4EHTTGAANPEPPSTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224223-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES NOVARTIS AG (CH) 2022-10-27 — — WO disclosed
Send feedback